Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Neoplasms | 5 | 2022 | 4262 | 0.800 |
Why?
|
| Transplants | 1 | 2022 | 209 | 0.700 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2021 | 3143 | 0.600 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2018 | 314 | 0.560 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2023 | 949 | 0.550 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2023 | 1101 | 0.540 |
Why?
|
| Proteoglycans | 1 | 2018 | 835 | 0.490 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 2007 | 0.400 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 8428 | 0.370 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3703 | 0.300 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3647 | 0.290 |
Why?
|
| Mice, Nude | 5 | 2020 | 3689 | 0.280 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 4034 | 0.280 |
Why?
|
| Cell Movement | 1 | 2018 | 5217 | 0.260 |
Why?
|
| Neoplastic Processes | 1 | 2023 | 35 | 0.240 |
Why?
|
| Tumor Microenvironment | 4 | 2022 | 3586 | 0.200 |
Why?
|
| Cricetulus | 1 | 2022 | 816 | 0.180 |
Why?
|
| Receptor, EphA6 | 1 | 2019 | 1 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 805 | 0.180 |
Why?
|
| CHO Cells | 1 | 2022 | 1406 | 0.170 |
Why?
|
| Activin Receptors, Type I | 1 | 2019 | 142 | 0.170 |
Why?
|
| Mucins | 1 | 2022 | 564 | 0.170 |
Why?
|
| Cricetinae | 1 | 2022 | 2472 | 0.160 |
Why?
|
| Chemokines, CXC | 1 | 2020 | 422 | 0.160 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2019 | 350 | 0.150 |
Why?
|
| Mucin-1 | 1 | 2022 | 543 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2021 | 1097 | 0.150 |
Why?
|
| Mice | 8 | 2022 | 81183 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 4 | 2018 | 6386 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 20822 | 0.140 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 16689 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13102 | 0.130 |
Why?
|
| Polysaccharides | 1 | 2022 | 1053 | 0.130 |
Why?
|
| Whole Body Imaging | 1 | 2017 | 280 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2540 | 0.120 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 142 | 0.120 |
Why?
|
| Smad4 Protein | 1 | 2015 | 163 | 0.120 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 2924 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2021 | 4217 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1276 | 0.100 |
Why?
|
| Animals | 9 | 2022 | 168757 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 2 | 2021 | 1376 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2018 | 3002 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 4851 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4204 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3507 | 0.080 |
Why?
|
| Neutrophils | 1 | 2020 | 3719 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2020 | 10252 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 2183 | 0.070 |
Why?
|
| Apoptosis | 2 | 2021 | 9727 | 0.070 |
Why?
|
| Disease Progression | 2 | 2020 | 13284 | 0.070 |
Why?
|
| Neoplasm Transplantation | 2 | 2021 | 2085 | 0.070 |
Why?
|
| Kidney | 1 | 2022 | 7186 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 9274 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2019 | 3481 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9438 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 29063 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2018 | 19229 | 0.050 |
Why?
|
| Electron Transport Complex III | 1 | 2021 | 31 | 0.050 |
Why?
|
| Male | 6 | 2022 | 350118 | 0.050 |
Why?
|
| Inflammation | 1 | 2020 | 10638 | 0.050 |
Why?
|
| Humans | 9 | 2023 | 744343 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2019 | 96 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 8863 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2018 | 23403 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 5256 | 0.040 |
Why?
|
| Female | 4 | 2023 | 380194 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2017 | 537 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2017 | 277 | 0.030 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2017 | 143 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 2015 | 74 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2019 | 838 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10481 | 0.030 |
Why?
|
| Chemokines | 1 | 2017 | 970 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2017 | 810 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 713 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 893 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 1758 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 1682 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 163280 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2849 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8436 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2021 | 4286 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 5892 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 4161 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 12797 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3505 | 0.020 |
Why?
|
| Glioma | 1 | 2019 | 3401 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11366 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 7722 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16365 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.010 |
Why?
|
| Brain | 1 | 2019 | 26385 | 0.010 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_